期刊文献+

Pharmacokinetic analysis and tissue distribution of Vam3 in the rat by a validated LC-MS/MS method 被引量:1

Pharmacokinetic analysis and tissue distribution of Vam3 in the rat by a validated LC-MS/MS method
原文传递
导出
摘要 Vam3 is a potential pharmacologically active ingiedient isolated from Vitis amurensis Rupr. A rapid, simple and sensitive method to determine Vam3 levels in rat plasma and tissue was developed based on EC-MS/MS. Vam3 and an internal standard (IS) were chromatographed on a C18 short column with acetonitrile-0.1% formic acid in water by gradient elution. MS detection was performed by electrospray ionization in negative ion multiple reaction monitoring modes,This method monitored the transitions m/z 451.0 -> 345.0 and m/z 301.0 -> 164.0 for Vam3 and IS, respectively. The calibration curve was linear over a concentration range of 1,64-1000 ng/mE, The inter-day and intra-day variabilities in precision was less than 12.8%, while the inter -day and intim-day accuracies ranged from 10.60% to 9.084 in plasma and tissue homogenates. This method was applied to investigate the pharmacokinetics and tissue distribution of Vain3 in rats. The results indicated that Vain3 had poor absorption into systemic circulation and extensive tissue distribution after oral administration, and the absolute bioavailability was low (0.79%). Vam3 had a relatively long terminal elimination half-life in lung, and the highest concentration was found in small intestinal tissue. The developed method and the pharmacokinetic data can provide a basis for further studies on the bioactivity of Vam3. (C) 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. Vam3 is a potential pharmacologically active ingredient isolated from Vitis amurensis Rupr.A rapid,simple and sensitive method to determine Vam3 levels in rat plasma and tissue was developed based on LC-MS/MS.Vam3 and an internal standard(IS) were chromatographed on a C18 short column with acetonitrile–0.1% formic acid in water by gradient elution.MS detection was performed by electrospray ionization in negative ion multiple reaction–monitoring modes.This method monitored the transitions m/z 451.0-345.0 and m/z 301.0-164.0 for Vam3 and IS,respectively.The calibration curve was linear over a concentration range of 1.64–1000 ng/m L.The inter-day and intra-day variabilities in precision was less than 12.8%,while the inter-day and intra-day accuracies ranged from –10.60% to9.08% in plasma and tissue homogenates.This method was applied to investigate the pharmacokinetics and tissue distribution of Vam3 in rats.The results indicated that Vam3 had poor absorption into systemic circulation and extensive tissue distribution after oral administration,and the absolute bioavailability was low(0.79%).Vam3 had a relatively long terminal elimination half-life in lung,and the highest concentration was found in small intestinal tissue.The developed method and the pharmacokinetic data can provide a basis for further studies on the bioactivity of Vam3.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2015年第3期254-263,共10页 药学学报(英文版)
基金 supported by the National Science and Technology Major Project Major New Drug of China (No.2012ZX09102101001)
关键词 Vam3 PHARMACOKINETICS Tissue distribution Absolve bioavialability LC-MS/MS Vam3 Pharmacokinetics Tissue distribution Absolute bioavailability LC-MS/MS
  • 相关文献

参考文献4

二级参考文献23

  • 1Yi-tang LI,Chun-suo YAO,Jin-ye BAI,Mao LIN,Gui-fang CHENG.Anti-inflammatory effect of amurensin H on asthma-like reaction induced by allergen in sensitized mice[J].Acta Pharmacologica Sinica,2006,27(6):735-740. 被引量:7
  • 2Kasserra CE, Harris P, Stenton GR, Abraham W, Langlands JM.IPL576,092, a novel anti-infiammatory compound, inhibits leukocyte infiltration and changes in lung function in response to allergen challenge. Pulm Pharmacol Ther 2004; 17: 309-18.
  • 3Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111: 291-7.
  • 4Frew AJ. Advances in environmental and occupational diseases 2004. J Allergy Clin Immunol 2005, 115:1197-202.
  • 5Hartert TV, Peebles RS Jr. Epidemiology of asthma: the year in review. Curr Opin Pulm Med 2000; 6: 4-9.
  • 6Masini E, Vannacci A, Giannini L, Bcfani O, Nistri S, Matccscu MA, et al. Effect of a plant histaminasc on asthma like reaction induced by inhaled antigen in sensitized guinea pig. Eur J Pharmacol 2004; 502: 253-64.
  • 7Drazen JM. Asthma therapy with agents preventing leukotriene synthesis or action. Proc Assoc Am Physicians 1999; 111: 547-59.
  • 8Spina D, Page CP. Asthma - a need for a rethink? Trends Pharmacol Sci 2002; 23:311-5.
  • 9Sullivan SD, Meltzer EO. Emerging therapeutic strategies for asthma management. J Manag Care Pharm 2003; 9: 14-21.
  • 10Huang KS, Lin M, Cheng GF. Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry 2001; 58: 357-62.

共引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部